OpenEvidence是一家面向医生的AI搜索引擎，是最新获得连续多轮融资的AI明星企业。据知情人士透露，该公司近期从医院系统和安德森·霍洛维茨基金（Andreessen Horowitz）获得了2.5亿美元的投资，估值达到150亿美元。今年1月，OpenEvidence完成新一轮融资，当时公司估值为120亿美元。据知情人士透露，OpenEvidence可能对包含算力获取的并购交易持开放态度，如果反AI情绪升温抑制了数据中心的扩张，算力在未来可能会变得更加稀缺。目前无法证实是否有潜在收购方对该公司的并购感兴趣，且OpenEvidence可能更倾向于保持独立。总部位于迈阿密的OpenEvidence在过去一年中已从Thrive Capital、DST、GV、Kleiner Perkins和红杉资本等投资者处筹集了超过10亿美元的资金。这家初创公司称，其AI驱动的搜索引擎是“历史上医生使用增长最快的应用程序”。在OpenAI、Anthropic和其他AI巨头加大医疗健康领域布局之际，新一轮融资随之而来。这些公司不再仅仅提供驱动其他公司产品的模型，而是越来越多地开发自己的医疗工具。作为一笔收购，OpenEvidence可能提供了一条捷径。它已经拥有使用其产品的医生、处理敏感医疗信息的经验，并在一个AI公司日益渴望掌控的庞大市场中占据了立足点。成立于2022年的OpenEvidence已被医疗专业人员广泛使用，超过三分之二的美国医生依赖该AI产品获取诊断和治疗建议。OpenEvidence与多家大型科技公司保持合作关系，并将英伟达（Nvidia）列为投资者之一。Anthropic本周宣布与该公司建立合作伙伴关系。OpenEvidence与谷歌和微软的AI工具均实现了集成。
OpenEvidence, an AI search engine for doctors, is the latest AI darling to raise back-to-back funding rounds. The company recently raised $250 million in investment from hospital systems and Andreessen Horowitz, valuing OpenEvidence at $15 billion, according to people familiar with the matter. In January, OpenEvidence raised a new round of funding that valued the company at $12 billion. OpenEvidence could be open to selling itself, which includes access to computing, which could become scarcer in the future if rising anti-AI sentiment curbs data center expansion, according to a person familiar with the matter. It could not be verified if the company has M&A interest from possible acquirers, and OpenEvidence may prefer to remain independent. Based in Miami, OpenEvidence has raised over $1 billion in the past year, from investors including Thrive Capital, DST, GV, Kleiner Perkins, and Sequoia Capital. The startup has called its AI-powered search engine "the fastest-growing application for physicians in history." The new funding round comes as OpenAI, Anthropic, and other AI giants make a bigger push into healthcare. Instead of just providing the models that power other companies' products, they're increasingly building healthcare tools of their own. As an acquisition, OpenEvidence could offer a shortcut. It already has doctors using its product, experience handling sensitive medical information, and a foothold in a massive market that AI companies increasingly want to own. Founded in 2022, OpenEvidence has already become widely used by medical professionals, with more than two-thirds of U.S. doctors relying on the AI product for its diagnostic and treatment advice, according to CNBC. OpenEvidence maintains relationships with several of the largest technology companies and counts Nvidia as an investor. Anthropic announced a partnership with the company this week. OpenEvidence integrates with both Google and Microsoft's AI tools. There has been a wave of major AI M&A lately, with Nvidia agreeing to buy HuggingFace for nearly $13 billion and Stripe agreeing to buy OpenRouter for around $8 billion, as the race to acquire AI talent remains strong.
近期出现了一波重大的人工智能并购浪潮，英伟达以近130亿美元收购了HuggingFace，Stripe则以约80亿美元收购了OpenRouter，争夺人工智能人才的竞赛依然激烈。
OpenEvidence, an AI search engine for doctors, is the latest AI darling to raise back-to-back funding rounds. The company recently raised $250 million in investment from hospital systems and Andreessen Horowitz, valuing OpenEvidence at $15 billion, according to people familiar with the matter. In January, OpenEvidence raised a new round of funding that valued the company at $12 billion. OpenEvidence could be open to selling itself, which includes access to computing, which could become scarcer in the future if rising anti-AI sentiment curbs data center expansion, according to a person familiar with the matter. It could not be verified if the company has M&A interest from possible acquirers, and OpenEvidence may prefer to remain independent. Based in Miami, OpenEvidence has raised over $1 billion in the past year, from investors including Thrive Capital, DST, GV, Kleiner Perkins, and Sequoia Capital. The startup has called its AI-powered search engine "the fastest-growing application for physicians in history." The new funding round comes as OpenAI, Anthropic, and other AI giants make a bigger push into healthcare. Instead of just providing the models that power other companies' products, they're increasingly building healthcare tools of their own. As an acquisition, OpenEvidence could offer a shortcut. It already has doctors using its product, experience handling sensitive medical information, and a foothold in a massive market that AI companies increasingly want to own. Founded in 2022, OpenEvidence has already become widely used by medical professionals, with more than two-thirds of U.S. doctors relying on the AI product for its diagnostic and treatment advice, according to CNBC. OpenEvidence maintains relationships with several of the largest technology companies and counts Nvidia as an investor. Anthropic announced a partnership with the company this week. OpenEvidence integrates with both Google and Microsoft's AI tools. There has been a wave of major AI M&A lately, with Nvidia agreeing to buy HuggingFace for nearly $13 billion and Stripe agreeing to buy OpenRouter for around $8 billion, as the race to acquire AI talent remains strong.